>>> US Research Calls I Upgrades: Allison Transmission (ALSN) upgraded to Buy fr

Research Calls I
  • Upgrades:
    • Allison Transmission (ALSN) upgraded to Buy from Neutral at Citi, tgt $135
    • Allstate (ALL) upgraded to Equal Weight from Underweight at Wells Fargo, tgt $236
    • AST SpaceMobile (ASTS) upgraded to Buy from Hold at Deutsche Bank, tgt $93
    • Biogen (BIIB) upgraded to Overweight from Neutral at JPMorgan, tgt $300
    • Blackstone Digital Infrastructure Trust (BXDC) upgraded to Buy from Neutral at Citi, tgt $20
    • Brown & Brown (BRO) upgraded to Outperform from Market Perform at Keefe, Bruyette & Woods, tgt $77
    • C3.ai (AI) upgraded to Outperform from Market Perform at Northland, tgt $16
    • First Solar (FSLR) upgraded to Buy from Hold at Truist, tgt $270
    • Hexcel (HXL) upgraded to Buy from Neutral at Seaport Research, tgt $104
    • Hub Group (HUBG) upgraded to Outperform from Neutral at Baird, tgt $29
    • Humana (HUM) upgraded to Outperform from Market Perform at Raymond James, tgt $520
    • Manhattan Associates (MANH) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $250
    • Mattel (MAT) upgraded to Buy from Neutral at Seaport Research, tgt $20
    • Salesforce (CRM) upgraded to Buy from Underperform at BofA Securities, tgt $285
    • SLM (SLM) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $30
    • T-Mobile (TMUS) upgraded to Outperform from Market Perform at Raymond James, tgt $170
    • Terreno Realty (TRNO) upgraded to Outperform from Market Perform at BMO Capital, tgt $75
    • Tyler Technologies (TYL) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $400
  • Downgrades:
    • Adobe (ADBE) downgraded to Underweight from Overweight at Wells Fargo, tgt $225
    • Alexandria Real Estate (ARE) downgraded to Underperform at BMO Capital, tgt $41
    • Ally Financial (ALLY) downgraded to Equal Weight from Overweight at Morgan Stanley, tgt $43
    • Baldwin Group (BWIN) downgraded to Market Perform from Outperform at Keefe, Bruyette & Woods, tgt $32.50
    • Enact Holdings (ACT) downgraded to Underweight from Neutral at JPMorgan, tgt $44
    • Fannie Mae (FNMA) downgraded to Neutral from Outperform at Mizuho, tgt $5
    • Freddie Mac (FMCC) downgraded to Neutral from Outperform at Mizuho, tgt $4
    • GoDaddy (GDDY) downgraded to Sector Perform from Outperform at RBC Capital, tgt $95
    • HubSpot (HUBS) downgraded to Equal Weight from Overweight at Barclays, tgt $240
    • Insmed (INSM) downgraded to Peer Perform from Outperform at Wolfe Research
    • Microsoft (MSFT) downgraded to Neutral from Accumulate at Phillip Securities, tgt $515
    • Monday.com (MNDY) downgraded to Equal Weight from Overweight at Barclays, tgt $100
    • Palantir (PLTR) downgraded to Neutral from Buy at Phillip Securities, tgt $215
    • Palo Alto Networks (PANW) downgraded to Neutral at Phillip Securities
    • Roivant Sciences (ROIV) downgraded to Peer Perform from Outperform at Wolfe Research
    • Snowflake (SNOW) downgraded to Accumulate from Buy at Phillip Securities, tgt $423
    • UWM Holdings (UWMC) downgraded to Neutral from Buy at BTIG
  • Others:
    • AbCellera Biologics (ABCL) initiated with a Buy at UBS, tgt $18
    • American Bitcoin (ABTC) assumed with a Buy at H.C. Wainwright, tgt $22
    • American Savings Bank (ASBH) initiated with a Buy at DA Davidson, tgt $20
    • American Savings Bank (ASBH) initiated with a Market Perform at Keefe, Bruyette & Woods, tgt $19
    • American Savings Bank (ASBH) initiated with an Overweight at Piper Sandler, tgt $20
    • AxoGen (AXGN) initiated with a Buy at BofA Securities, tgt $52
    • Beta Bionics (BBNX) initiated with a Buy at Jefferies, tgt $30
    • BioAge Labs (BIOA) initiated with a Neutral at UBS, tgt $8
    • Butterfly Network (BFLY) initiated with a Buy at Canaccord, tgt $10
    • Charles Schwab (SCHW) initiated with an In Line at Evercore ISI, tgt $107
    • Connect Biopharma (CNTB) assumed with an Outperform at Leerink, tgt $4
    • Equillium (EQ) assumed with an Outperform at Leerink, tgt $6
    • Evommune (EVMN) initiated with a Neutral at UBS, tgt $8
    • First Financial (THFF) initiated with an Outperform at Hovde Group, tgt $85
    • Hartford Financial Services (HIG) initiated with a Hold at Truist, tgt $137
    • IDEXX Laboratories (IDXX) initiated with a Sector Weight at KeyBanc
    • Interactive Brokers (IBKR) initiated with an Outperform at Evercore ISI, tgt $100
    • Kardigan (KARD) initiated with a Buy at UBS, tgt $25
    • Mineralys Therapeutics (MLYS) initiated with a Neutral at UBS, tgt $29
    • MiniMed (MMED) initiated with a Hold at Jefferies, tgt $22
    • Nektar Therapeutics (NKTR) initiated with an Outperform at Leerink, tgt $130
    • Nektar Therapeutics (NKTR) initiated with a Neutral at UBS, tgt $53
    • Ocular Therapeutix (OCUL) initiated with a Buy at UBS, tgt $14
    • Odyssey Therapeutics (ODTX) initiated with a Buy at UBS, tgt $27
    • Prenetics (PRE) initiated with a Buy at Lucid Capital Markets, tgt $54
    • Protagonist Therapeutics (PTGX) initiated with a Buy at UBS, tgt $184
    • Q32 Bio (QTTB) initiated with an Outperform at Leerink, tgt $40
    • Quoin Pharmaceuticals (QNRX) initiated with a Buy at BTIG, tgt $14
    • Robinhood (HOOD) initiated with an Outperform at Evercore ISI, tgt $130
    • Shattuck Labs (STTK) initiated with a Buy at UBS, tgt $17
    • Spyre Therapeutics (SYRE) initiated with a Buy at UBS, tgt $120
    • Tectonic Therapeutics (TECX) initiated with a Neutral at UBS, tgt $26
    • TeraWulf (WULF) initiated with a Buy at TD Cowen, tgt $21
    • Vera Therapeutics (VERA) initiated with a Market Perform at Leerink, tgt $34
    • Vylor (VYLR) initiated with a Buy at UBS, tgt $89